Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.0 - 0.0
Trade Value (12mth)
N/A
1 week
-2.22%
1 month
-12%
YTD
-70.34%
1 year
-77.75%
All time high
N/A
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Shares on Issue (Fully Dilluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
N/A
Short Sell (% of issue)
N/A
Date | Announcements |
---|---|
31 October 23 |
Activities Update Qtr Ending September 2023 and Appendix 4C
×
Activities Update Qtr Ending September 2023 and Appendix 4C |
31 October 22 |
Activities Update Qtr Ending September 2022 and Appendix 4C
×
Activities Update Qtr Ending September 2022 and Appendix 4C |
31 May 22 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
31 March 23 |
OSX Completes Acquisition to Accelerate Revenue Growth
×
OSX Completes Acquisition to Accelerate Revenue Growth |
31 March 23 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
31 March 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 March 23 |
Results of General Meeting
×
Results of General Meeting |
31 March 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 March 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 July 23 |
Activities Update Qtr Ending June 2023 and Appendix 4C
×
Activities Update Qtr Ending June 2023 and Appendix 4C |
31 July 23 |
Initial Director's Interest Notice - MK
×
Initial Director's Interest Notice - MK |
31 January 23 |
Activities Update Qtr Ending December 2022 and Appendix 4C
×
Activities Update Qtr Ending December 2022 and Appendix 4C |
31 August 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
31 August 22 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
30 November 23 |
Negotiation ongoing for InnoVentures Definitive JV Agreement
×
Negotiation ongoing for InnoVentures Definitive JV Agreement |
30 May 23 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
30 March 23 |
Non-Renounceable Entitlement Offer Extension
×
Non-Renounceable Entitlement Offer Extension |
30 March 23 |
Update - Proposed issue of securities - OSX
×
Update - Proposed issue of securities - OSX |
29 June 23 |
Application for quotation of securities - OSX
×
Application for quotation of securities - OSX |
29 December 21 |
Change to the Board of Directors
×
Change to the Board of Directors |
29 December 21 |
Appendix 3X
×
Appendix 3X |
29 August 23 |
Timeline extended for definitive agreements with CellHeal
×
Timeline extended for definitive agreements with CellHeal |
29 April 22 |
Activities Update Qtr Ending March 2022 and Appendix 4C
×
Activities Update Qtr Ending March 2022 and Appendix 4C |
29 April 22 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
29 April 21 |
Notice of Annual General Meeting
×
Notice of Annual General Meeting |
28 September 22 |
More Osteopore Products Available on Prostheses List
×
More Osteopore Products Available on Prostheses List |
28 September 22 |
Chile Government and University co-fund Osteopore research
×
Chile Government and University co-fund Osteopore research |
28 May 21 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.